Immune Checkpoint Inhibitor Metastatic NSCLC: Combination Strategies - Episode 3

Rationale for Treatment of mNSCLC with Immune Checkpoint Inhibitors

Dr Edward B. Garon explains the rationale for treating patients with mNSCLC with a frontline combination of chemotherapy and immune checkpoint inhibitors.